Skip to main content
. 2014 Sep 11;4(3):166–173. doi: 10.1556/EUJMI-D-14-00014

Table 3.

Performance of MTBDRplus compared to drug susceptibility testing

Drug susceptibility testing Performances
Rifampin 64 15 Sensitivity: 100% (75.6–100%)
Specificity: 73.2% (61.3–84%)
PPV: 81% (72–90%)
0 41 NPV: 100% (69–100%)
75 2 Sensitivity: 95% (90–99%)

Isoniazid Specificity: 95.1% (88.5–100%)
4 39 PPV: 97.4% (94–100%)
NPV: 90.7% (82–99%)

PPV: positive predictive value; NPV: negative predictive value